DANVERS, Mass., July 26 /PRNewswire-FirstCall/ -- Medwave, Inc. , the innovator in sensor-based, non-invasive blood pressure measuring solutions, announced today that it has entered into a distribution agreement with Tri-anim of Sylmar, California. Recognized as the nation's largest provider of specialty sales and distribution solutions for healthcare, Tri-anim will integrate Medwave's Primo(TM) spot blood pressure monitor into the innovative suite of offerings represented by its nationwide acute care sales team.
Primo is a handheld, sensor-based, non-invasive device for measuring blood pressure. Representing the first major innovation to cuff- and mercury-based blood pressure measurement in more than 100 years, Primo has gained rapid acceptance among medical professionals and their patients due to its unique combination of speed, accuracy, flexibility and comfort. The Tri-anim agreement is part of Medwave's overall strategy to expand product distribution by teaming with reputable partners in key national and international regions.
"We are excited to enter into this agreement with Tri-anim, one of the truly dominant medical device distribution companies for specialty products," said Tim O'Malley, Medwave President and CEO. "Primo has proven market pull, and by combining Medwave's core sales team with a larger, entrenched, very accomplished Tri-anim sales force, the market will benefit from greater access to a cost-effective product that improves efficiency without sacrificing accuracy."
About Tri-anim
Tri-anim is the nation's largest provider of specialty sales and distribution solutions for healthcare. For more than 30 years, Tri-anim has met the needs and exceeded the expectations of providers throughout the healthcare continuum, including hospitals, long-term care facilities, surgery centers, nursing homes and emergency medical services (EMS). Tri-anim has more than 200 sales and customer service professionals serving customers throughout the United States.
All orders placed, right up until 5 p.m., are shipped same day from one of 13 nationwide distribution centers. Tri-anim's fill-rate is over 99 percent on regularly ordered items. Tri-anim is an industry leader in providing e- commerce solutions that make it faster and more efficient for customers to procure medical products. This includes the e-Quick(R) System, a patent- pending technology created by Tri-anim that requires less than 45 seconds to place a five-line order.
About Medwave
Medwave, Inc. develops, manufactures and distributes sensor-based non- invasive blood pressure solutions. Medwave's suite of products is designed for use in hospitals, clinics, doctor's offices and almost anywhere blood pressure monitoring occurs. Medwave has the required technology clearances to market its technology in the United States, Europe and Asia. Medwave's technology is installed in more than 500 hospitals and clinics worldwide. Medwave trades on the NASDAQ small cap market under the symbol MDWV. For more information, visit http://www.medwave.com .
Statements made in this release that are stated as expectations, plans, anticipations, prospects or future estimates or which otherwise look forward in time are considered "forward-looking statements" and involve a variety of risks and uncertainties, known and unknown, which are likely to affect the actual results. The following factors, among others, as well as factors discussed in Medwave's filings with the SEC, have affected and, in the future, could affect Medwave's actual results: resistance to the acceptance of new medical products, the market acceptance of the Primo(TM) system, the Vasotrac(R) system and other products of Medwave, hospital budgeting cycles, the possibility of adverse or negative results or commentary from clinical researchers or other users or evaluators of Medwave's products, Medwave's success in creating effective distribution channels for its products, Medwave's ability to scale up its manufacturing process, and delays in product development or enhancement or regulatory approval. Consequently, no forward- looking statement can be guaranteed and actual results may vary materially. Medwave(R), Vasotrac(R), Legato(TM), Primo(TM), and Fusion(TM) are trademarks of Medwave, Inc.
Medwave, Inc.CONTACT: Investor Relations, Jodie Chastain, +1-800-894-7601, or MediaRelations, Kevin Sawyer, +1-612-465-8356, both of Medwave, Inc.
